2025-04-23 | 84421Financial Services Commission Chairman Kim Byoung Hwan visited Boston and New York to seek regulatory improvements for Korea's biotech venture investment and strengthen ties with U.S. financial institutions. During the Boston leg, he engaged with venture capitalists and LG Chem's AVEO Oncology to address declining biotech investments and pledged government support for public capital injection and professional networking. In New York, Chairman Kim met with Blackstone CEO Stephen Schwarzman and Korean financial firms to discuss capital market reforms, tariff impacts, and efforts to eliminate redundant reporting requirements for overseas operations.